Fineblue Injection
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
MFDS item code 201505707 · Notified 2015.08.13
Prevention of trace element deficiencies during parenteral nutrition
Administering trace elements together during intravenous nutritional supply is very important for improving the overall nutritional status of patients and preventing complications caused by trace element deficiencies. Trace elements help the functions of various enzymes in the body and play a role in enhancing immunity. Therefore, they are essential for preventing nutritional imbalances in the body and supporting proper metabolic activities.
Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment. Patients receiving metabolically stable parenteral nutrition: zinc 2.5~4㎎ daily, copper 0.5~1.5㎎ daily, manganese 0.15~0.8㎎ daily, chromium 10~15㎍ daily Patients with small intestinal fluid loss: an additional 12.2mg/L (volume of small intestinal fluid loss) or 17.1mg/kg (stool output), 20㎍ daily Patients with acute catabolic states: 4.5~6mg daily
Pediatric patients -5 years of age or younger: zinc 100㎍ per kg of body weight daily Pediatric patients - premature infants weighing 3kg or less: zinc 300㎍ per kg of body weight daily Pediatric patients: copper 20㎍ per kg of body weight daily Pediatric patients: manganese 2~10㎍ per kg of body weight daily Pediatric patients: chromium 0.14~0.20㎍ per kg of body weight daily
This medication should be diluted before use; if administered undiluted through intravenous injection, it may cause inflammation in blood vessels. This medication should only be used when mixed with other drugs for injection as it is a low osmotic pressure solution. If any component of this medication causes toxic effects, administration must be stopped immediately. The zinc, copper, manganese, and chromium contained in this medication are in very small amounts, so toxic symptoms are not generally observed within the prescribed dosage. Before injection, physicians should carefully assess the patient's health status and the amount of nutrients the body requires. Zinc is primarily eliminated through the kidneys, so caution is needed for patients with impaired kidney function as zinc may accumulate in the body. Copper and manganese are mainly excreted through bile; therefore, patients with biliary problems may be at risk of accumulation of these components. Manganese is also eliminated through pancreatic juice and may be partially reabsorbed in the intestines, which can affect manganese concentration in the body. Chromium may affect blood glucose control, so diabetic patients must confirm their use of diabetes medications before taking this medicine. Women who are pregnant or may become pregnant should use this medication only when the benefits of treatment outweigh potential risks, as its safety has not been fully established. Excessive intake of zinc can cause serious symptoms, including nausea, vomiting, dehydration, dizziness, abdominal pain, drowsiness, loss of coordination, weakness, behavioral abnormalities, diarrhea, progressive wasting syndrome, muscle tone reduction, glare, peripheral edema, nausea, vomiting, ulcers, kidney disorders, liver disorders, seizures, and coma. Excessive intake of copper can result in symptoms such as fatigue, behavioral abnormalities, diarrhea, decreased muscle tone, glare, and swelling; D-penicillamine can be used as an antidote. Toxicity from excessive manganese intake has been reported infrequently in patients receiving parenteral nutrition, but no toxicity is known from normal food or beverage consumption. Excessive chromium intake may cause nausea, vomiting, ulcers, renal and hepatic dysfunction, and in severe cases, seizures and coma; caution is advised. This medication must be used strictly according to a physician’s prescription and should not be used arbitrarily without a prescription. When adding this medication to parenteral nutritional solutions, it is recommended to work in a laminar flow environment to maintain a sterile condition for infection prevention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and moisture ingress, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents degradation.
A light blue transparent liquid contained in a colorless and transparent vial for injection
2mL/vial x 10 vials
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Huons Co., Ltd.
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Green Cross Wellbeing Co., Ltd.
Zinc Sulfate Hydrate · Cupric Sulfate Hydrate +2 more
Prescription medication · Combination
Donggu Biopharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.